Trillium Therapeutics Inc. announced the key additions to its leadership team: Blythe Thomson, MD, Executive Medical Director, Jane E. Cole, RN, Senior Director, Clinical Operations, and Brian E. Jahns, PharmD, Senior Vice President, Commercial and Business Development. The company also announced that Eric Sievers, MD, has transitioned from Chief Medical Officer to Senior Clinical Advisor. In this new role, Dr. Sievers will maintain a close association with the company's clinical programs and advisors, and continue to assist Trillium with clinical strategy and communications. The company is now initiating the process of identifying Dr. Sievers' successor.